316 related articles for article (PubMed ID: 10746740)
1. De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes.
Salamon D; Takacs M; Myöhänen S; Marcsek Z; Berencsi G; Minarovits J
Biol Chem; 2000 Feb; 381(2):95-105. PubMed ID: 10746740
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes.
Takacs M; Salamon D; Myöhänen S; Li H; Segesdi J; Ujvari D; Uhlig J; Niller HH; Wolf H; Berencsi G; Minarovits J
Biol Chem; 2001 Apr; 382(4):699-705. PubMed ID: 11405234
[TBL] [Abstract][Full Text] [Related]
3. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region.
Falk K; Ernberg I
Virology; 1993 Aug; 195(2):608-15. PubMed ID: 8393238
[TBL] [Abstract][Full Text] [Related]
4. Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines.
Niller HH; Salamon D; Takacs M; Uhlig J; Wolf H; Minarovits J
Biol Chem; 2001 Oct; 382(10):1411-9. PubMed ID: 11727824
[TBL] [Abstract][Full Text] [Related]
5. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation.
Nonkwelo CB; Long WK
Virology; 1993 Nov; 197(1):205-15. PubMed ID: 8212555
[TBL] [Abstract][Full Text] [Related]
7. The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1.
Bochkarev A; Bochkareva E; Frappier L; Edwards AM
J Mol Biol; 1998 Dec; 284(5):1273-8. PubMed ID: 9878348
[TBL] [Abstract][Full Text] [Related]
8. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
9. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
10. Visualization of DNA replication on individual Epstein-Barr virus episomes.
Norio P; Schildkraut CL
Science; 2001 Dec; 294(5550):2361-4. PubMed ID: 11743204
[TBL] [Abstract][Full Text] [Related]
11. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
Minarovits J; Minarovits-Kormuta S; Ehlin-Henriksson B; Falk K; Klein G; Ernberg I
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1591-9. PubMed ID: 1649897
[TBL] [Abstract][Full Text] [Related]
12. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
[TBL] [Abstract][Full Text] [Related]
13. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.
Cotter MA; Subramanian C; Robertson ES
Virology; 2001 Dec; 291(2):241-59. PubMed ID: 11878894
[TBL] [Abstract][Full Text] [Related]
14. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1.
Sugawara Y; Makuuchi M; Kato N; Shimotohno K; Takada K
EMBO J; 1999 Oct; 18(20):5755-60. PubMed ID: 10523318
[TBL] [Abstract][Full Text] [Related]
17. Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing.
Takacs M; Myöhänen S; Altiok E; Minarovits J
Biol Chem; 1998; 379(4-5):417-22. PubMed ID: 9628332
[TBL] [Abstract][Full Text] [Related]
18. Expression of latent Epstein-Barr virus genomes in human epithelial/Burkitt's lymphoblastoid hybrid cells.
Nonoyama M; Tanaka A; Glaser R
IARC Sci Publ (1971); 1978; (20):397-402. PubMed ID: 215523
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
20. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]